Select Vaccines sells 100% stake in Hepgenics - MarketLine Financial Deals

Select Vaccines sells 100% stake in Hepgenics

Select Vaccines sells 100% stake in Hepgenics - MarketLine Financial Deals
Select Vaccines sells 100% stake in Hepgenics
Published Sep 10, 2010
2 pages — Published Sep 10, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Select Vaccines Limited, a developer of VLP vaccines, anti-viral therapeutics and diagnostics, has sold its 100% stake in Hepgenics Pty Ltd, a research and development services provider.

  
Source:
Document ID
MA93029_111229
Country
Ticker
SLT=AU
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Select Vaccines sells 100% stake in Hepgenics" Sep 10, 2010. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Select-Vaccines-sells-100-stake-in-Hepgenics-2052-75388>
  
APA:
MarketLine Financial Deals. (2010). Select Vaccines sells 100% stake in Hepgenics Sep 10, 2010. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Select-Vaccines-sells-100-stake-in-Hepgenics-2052-75388>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.